Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039649 | SCV000063338 | likely benign | not specified | 2016-07-07 | criteria provided, single submitter | clinical testing | p.Ile2858Val in exon 38 of GPR98: This variant is not expected to have clinical significance because the isoleucine (Ile) at position 2858 is not conserved thro ugh species with 8 mammals having a valine (Val) at this position. In addition, this variant has been identified in 0.1% (91/65792) of European chromosomes an d in 0.2% (15/6590) of Finnish chromosomes by the Exome Aggregation Consortium ( ExAC, http://exac.broadinstitute.org; dbSNP rs41308297). |
Eurofins Ntd Llc |
RCV000514669 | SCV000229918 | uncertain significance | not provided | 2017-05-15 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514669 | SCV000610710 | uncertain significance | not provided | 2017-07-06 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000039649 | SCV000840692 | likely benign | not specified | 2024-04-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000514669 | SCV001032210 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001154703 | SCV001316083 | uncertain significance | Usher syndrome type 2C | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV000514669 | SCV001836155 | benign | not provided | 2019-09-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000039649 | SCV001921931 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000514669 | SCV001926661 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000514669 | SCV001967043 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004549471 | SCV004749617 | likely benign | ADGRV1-related disorder | 2022-02-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |